← World Watch
Disruptionother · June 16, 2026
Dimerix exclusively licenses DMX-200 in Greater China, South Korea and Southeast Asia to Everest Medicines
A licensing deal shifts regional rights for DMX-200, affecting future availability and production/commercialization of the drug in those markets.
Source →The trace
How it reaches your house.
Starting from the trigger, we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
The causal trace for this event is still being written.